Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial

Abstract Background Nocturia is one of the most bothersome lower urinary tract symptoms and often impairs sleep quality in the elderly. Although previous studies on nocturia have indicated that the successful treatment of nocturia improves sleep quality, most used questionnaires and activity devices...

Full description

Bibliographic Details
Main Authors: Kazumasa Torimoto, Makito Miyake, Yasushi Nakai, Katsuya Aoki, Nobumichi Tanaka, Kiyohide Fujimoto
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Urology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12894-020-00668-5
_version_ 1819113227123949568
author Kazumasa Torimoto
Makito Miyake
Yasushi Nakai
Katsuya Aoki
Nobumichi Tanaka
Kiyohide Fujimoto
author_facet Kazumasa Torimoto
Makito Miyake
Yasushi Nakai
Katsuya Aoki
Nobumichi Tanaka
Kiyohide Fujimoto
author_sort Kazumasa Torimoto
collection DOAJ
description Abstract Background Nocturia is one of the most bothersome lower urinary tract symptoms and often impairs sleep quality in the elderly. Although previous studies on nocturia have indicated that the successful treatment of nocturia improves sleep quality, most used questionnaires and activity devices to analyze sleep/wake patterns. Therefore, there is little information about the treatment effects of desmopressin on objective sleep quality. The aim of the DISTINCT study is to investigate the change in subjective and objective sleep quality using electroencephalography (EEG) and the Pittsburgh Sleep Quality Index (PSQI) after the administration of desmopressin in patients with nocturia due to nocturnal polyuria. Methods A total of 20 male patients, ≥65 years old, with nocturnal polyuria, defined as a nocturnal polyuria index (NPi) (nocturnal urine volume / 24 h urine volume) value ≥0.33, will participate in this study. The participants must have a nocturnal frequency of ≥2 and the first uninterrupted sleep period (FUSP) must occur within < 2.5 h. Desmopressin 50 μg per day will be orally administered before going to bed for 4 weeks. Urinary frequency volume charts (FVC) and EEG will be recorded prior to treatment and at 1 week and 4 weeks after the initiation of treatment. The PSQI will be completed before and 4 weeks after treatment. The primary endpoint is the change from baseline in the mean time of slow-wave sleep (sleep stages N3 and N4) at 4 weeks. The secondary endpoints include the change in the mean value of each sleep variable, the mean delta power during the FUSP, the correlation between nocturnal urinary frequency and slow-wave sleep time, and the change in PSQI score before and after treatment. Discussion The DISTINCT study will provide valuable evidence to indicate that oral desmopressin treatment for nocturnal polyuria prolongs the FUSP, resulting in the extension of slow-wave sleep time associated with sleep quality. Trial registration The Japan Registry of Clinical Trials ( jRCTs051190080 ). Registered 9 December, 2019.
first_indexed 2024-12-22T04:26:03Z
format Article
id doaj.art-7de391bf77e34bf18ec2abed0c176263
institution Directory Open Access Journal
issn 1471-2490
language English
last_indexed 2024-12-22T04:26:03Z
publishDate 2020-07-01
publisher BMC
record_format Article
series BMC Urology
spelling doaj.art-7de391bf77e34bf18ec2abed0c1762632022-12-21T18:39:10ZengBMCBMC Urology1471-24902020-07-012011610.1186/s12894-020-00668-5Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trialKazumasa Torimoto0Makito Miyake1Yasushi Nakai2Katsuya Aoki3Nobumichi Tanaka4Kiyohide Fujimoto5Department of Urology, Nara Medical UniversityDepartment of Urology, Nara Medical UniversityDepartment of Urology, Nara Medical UniversityDepartment of Urology, Nara Medical UniversityDepartment of Urology, Nara Medical UniversityDepartment of Urology, Nara Medical UniversityAbstract Background Nocturia is one of the most bothersome lower urinary tract symptoms and often impairs sleep quality in the elderly. Although previous studies on nocturia have indicated that the successful treatment of nocturia improves sleep quality, most used questionnaires and activity devices to analyze sleep/wake patterns. Therefore, there is little information about the treatment effects of desmopressin on objective sleep quality. The aim of the DISTINCT study is to investigate the change in subjective and objective sleep quality using electroencephalography (EEG) and the Pittsburgh Sleep Quality Index (PSQI) after the administration of desmopressin in patients with nocturia due to nocturnal polyuria. Methods A total of 20 male patients, ≥65 years old, with nocturnal polyuria, defined as a nocturnal polyuria index (NPi) (nocturnal urine volume / 24 h urine volume) value ≥0.33, will participate in this study. The participants must have a nocturnal frequency of ≥2 and the first uninterrupted sleep period (FUSP) must occur within < 2.5 h. Desmopressin 50 μg per day will be orally administered before going to bed for 4 weeks. Urinary frequency volume charts (FVC) and EEG will be recorded prior to treatment and at 1 week and 4 weeks after the initiation of treatment. The PSQI will be completed before and 4 weeks after treatment. The primary endpoint is the change from baseline in the mean time of slow-wave sleep (sleep stages N3 and N4) at 4 weeks. The secondary endpoints include the change in the mean value of each sleep variable, the mean delta power during the FUSP, the correlation between nocturnal urinary frequency and slow-wave sleep time, and the change in PSQI score before and after treatment. Discussion The DISTINCT study will provide valuable evidence to indicate that oral desmopressin treatment for nocturnal polyuria prolongs the FUSP, resulting in the extension of slow-wave sleep time associated with sleep quality. Trial registration The Japan Registry of Clinical Trials ( jRCTs051190080 ). Registered 9 December, 2019.http://link.springer.com/article/10.1186/s12894-020-00668-5NocturiaNocturnal polyuriaDesmopressinSleep qualitySlow-wave sleepDelta power
spellingShingle Kazumasa Torimoto
Makito Miyake
Yasushi Nakai
Katsuya Aoki
Nobumichi Tanaka
Kiyohide Fujimoto
Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial
BMC Urology
Nocturia
Nocturnal polyuria
Desmopressin
Sleep quality
Slow-wave sleep
Delta power
title Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial
title_full Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial
title_fullStr Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial
title_full_unstemmed Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial
title_short Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial
title_sort rationale design and methods of electroencephalography based investigation of the effects of oral desmopressin on improving slow wave sleep time in nocturnal polyuria patients the distinct study protocol for a single arm open label single assignment trial
topic Nocturia
Nocturnal polyuria
Desmopressin
Sleep quality
Slow-wave sleep
Delta power
url http://link.springer.com/article/10.1186/s12894-020-00668-5
work_keys_str_mv AT kazumasatorimoto rationaledesignandmethodsofelectroencephalographybasedinvestigationoftheeffectsoforaldesmopressinonimprovingslowwavesleeptimeinnocturnalpolyuriapatientsthedistinctstudyprotocolforasinglearmopenlabelsingleassignmenttrial
AT makitomiyake rationaledesignandmethodsofelectroencephalographybasedinvestigationoftheeffectsoforaldesmopressinonimprovingslowwavesleeptimeinnocturnalpolyuriapatientsthedistinctstudyprotocolforasinglearmopenlabelsingleassignmenttrial
AT yasushinakai rationaledesignandmethodsofelectroencephalographybasedinvestigationoftheeffectsoforaldesmopressinonimprovingslowwavesleeptimeinnocturnalpolyuriapatientsthedistinctstudyprotocolforasinglearmopenlabelsingleassignmenttrial
AT katsuyaaoki rationaledesignandmethodsofelectroencephalographybasedinvestigationoftheeffectsoforaldesmopressinonimprovingslowwavesleeptimeinnocturnalpolyuriapatientsthedistinctstudyprotocolforasinglearmopenlabelsingleassignmenttrial
AT nobumichitanaka rationaledesignandmethodsofelectroencephalographybasedinvestigationoftheeffectsoforaldesmopressinonimprovingslowwavesleeptimeinnocturnalpolyuriapatientsthedistinctstudyprotocolforasinglearmopenlabelsingleassignmenttrial
AT kiyohidefujimoto rationaledesignandmethodsofelectroencephalographybasedinvestigationoftheeffectsoforaldesmopressinonimprovingslowwavesleeptimeinnocturnalpolyuriapatientsthedistinctstudyprotocolforasinglearmopenlabelsingleassignmenttrial